Multimodal Assesment of Acute Cardiac Toxicity Induced by Thoracic Radiotherapy in Cancer Patients
NCT04896242 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 47
Last updated 2024-04-04
Summary
The purpose of this study is to evaluate and compare the changes by two modalities: Imaging by Strain by Speckle Tracking and Magnetic Resonance versus soluble markers of cardiac dysfunction as early predictors of cardio-toxicity in cancer patients receiving low or high doses of radiotherapy.
Conditions
- Radiotherapy; Complications
- Cardiotoxicity
- Cancer
- Lung Cancer
- Breast Cancer
- Esophageal Cancer
Sponsors & Collaborators
-
Pontificia Universidad Catolica de Chile
lead OTHER
Principal Investigators
-
Tomas Merino Lara · Pontificia Universidad Catolica de Chile
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-01-09
- Primary Completion
- 2022-10-31
- Completion
- 2024-04-01
Countries
- Chile
Study Locations
More Related Trials
-
Effectiveness of Stereotactic RadioTherapy in Solid Primary Inoperable and Oligometastatic Cancer
NCT03461822 ·Status: UNKNOWN
-
Monitoring Radiobiological Effects in Thoracic Malignancy by Using Myocardial Perfusion Scan
NCT01913769 ·Status: UNKNOWN
-
High-precision Radiotherapy of Motor Deficits Due to Metastatic Spinal Cord Compression
NCT03070431 ·Status: COMPLETED ·Phase: NA
-
Hypofractionated Radiotherapy in Breast Cancer
NCT03167359 ·Status: COMPLETED ·Phase: NA
-
Stereotactic Ablative Body Radiotherapy (SABR) for Oligometastases
NCT02933242 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Characterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes
NCT04183218 ·Status: COMPLETED
-
Detecting Radiation-Induced Cardiac Toxicity After Non-Small Cell Lung Cancer Radiotherapy
NCT03416972 ·Status: UNKNOWN
-
Radiofrequency Ablation (RFA) in Breast Tumors
NCT04389216 ·Status: COMPLETED ·Phase: NA
-
Stereotactic Volumetric Radiotherapy in Prostate Cancer
NCT02423889 ·Status: COMPLETED ·Phase: PHASE2
-
Avoiding Cardiac Toxicity in Lung Cancer Patients Treated With Curative-intent Radiotherapy
NCT03645317 ·Status: UNKNOWN ·Phase: NA
-
REBECCA Study (RadiothErapy for BrEast Cancer and CArdiotoxicity)
NCT02079272 ·Status: WITHDRAWN ·Phase: NA
-
Predictors of Radiation Pneumonitis in Locally Advanced Lung Cancer Treated With Chemoradiation
NCT01580579 ·Status: COMPLETED
-
Accelerated Hypofractionated Radiotherapy in the Treatment of Malignant Pleural Mesothelioma
NCT03269227 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Unusual Toxicity Induced by Radiotherapy
NCT03980977 ·Status: COMPLETED ·Phase: NA
-
Predictors of Normal Tissue Response From the Microenvironment in Radiotherapy for Prostate and Head-and-neck Cancer
NCT03294122 ·Status: UNKNOWN
-
Improving the Success Rate for Thoracic Radiotherapy Through Specific Cardiac Substructure Dosimetry: Location Matters. (LOCATION MATTERS)
NCT06361784 ·Status: RECRUITING
-
Stereotactic Body Radiotherapy for Head and Neck Tumors
NCT01344356 ·Status: COMPLETED ·Phase: PHASE4
-
Echocardiography for RILI Prediction
NCT02501707 ·Status: TERMINATED
-
Cryoablation in Combination (or Not) With Pembrolizumab and Pemetrexed-carboplatin in 1st-line Treatment for Patients With Metastatic Lung Adenocarcinoma
NCT04339218 ·Status: RECRUITING ·Phase: PHASE3
-
Radiotherapy for Extracranial Oligometastatic Breast Cancer
NCT04646564 ·Status: RECRUITING ·Phase: PHASE3
-
Coagulation System In STereotactic Radiotherapy Of NSCLC
NCT03893461 ·Status: UNKNOWN
-
Curatively Intended Thoracic Reirradiation
NCT06950073 ·Status: RECRUITING
-
Atezolizumab and BEvacizumab With STereotactic Body Radiotherapy for Advanced Hepatocellular Carcinoma
NCT06595108 ·Status: RECRUITING ·Phase: NA
-
Toward High Fidelity Adaptive Radiotherapy in the Thorax
NCT04731571 ·Status: COMPLETED
-
Randomized Trial Comparing Stereotactic Body Radiation Therapy to Microwave Ablation for the Treatment of Localized Hepatocellular Carcinoma
NCT03168152 ·Status: WITHDRAWN ·Phase: NA